DelveInsight’s ABSSSI market report gives a thorough understanding of Acute Bacterial Skin and Skin-Structure Infection. It provides ABSSSI treatment algorithms and ABSSSI treatment guidelines in the US, Europe, and Japan. The ABSSSI market outlook of the report helps to build the detailed comprehension of the historical, current and forecasted trend of the ABSSSI market by analysing the impact of current therapies on the market, unmet needs, ABSSSI market drivers and ABSSSI market barriers and demand of better technology. For more information on ABSSSI market, click here: <a href="https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infection-absssi-market-insights-epidemiology-and-market-forecast">ABSSSI Market</a>

1. Acute Bacterial Skin and
Skin Structure Infections

2. 05
04
03
02
01
Despite recent ABSSSI antibiotic launches, unmet needs still exist for an
oral anti-MRSA agent.
ABSSSI consists of the most frequently diagnosed skin infections
worldwide.
The ABSSSI symptoms observed are extensive cellulitis, wound
infection, major cutaneous abscesses, and burn infections.
ABSSSI types can be community-acquired or hospital-acquired, and the
predisposing factors include trauma, chronic cutaneous lesions etc.
ABSSSI is defined as a bacterial infection of Skin with a lesion size area
of ≥75 cm2.
DelveInsight © 2019 | All rights reserved
Acute Bacterial Skin and Skin Structure Infections
(ABSSSI)

3. DelveInsight © 2019 | All rights reserved
ABSSSI Epidemiology
• In United States, more than 15 million
bacterial skin and skin structure
infections occur.
• ABSSSI total 7MM* Incident cases in
2017 were 7,259,777, out of which
ABSSSI highest Incident cases were seen
in the United States.
• There were 1,942,229 male patients
and 1,406,442 female cases suffering
from ABSSSI in 2017 in the United States.
*7MM:- Unites States; EU 5 (Germany, France,
Spain, Italy, United Kingdom); Japan.

4. The ABSSSI therapeutic approaches
favored in treating skin infections
include adjunctive therapies, early
and appropriate empiric antibiotic
therapy, wound culture with
susceptibility testing and surgical
drainage and debridement.
A large number of upcoming
pipeline drugs, is expected
to create a lucrative
environment for growth of
ABSSSI treatment market.
Oral and intravenous options for ABSSSI
treatment with activity against MRSA include
several long-standing therapies, such as
clindamycin, doxycycline etc.
ABSSSI treatment includes
an antimicrobial therapy,
surgical drainage, and
antibiotic therapy.
ABSSSI Treatment
DelveInsight © 2019 | All rights reserved

5. Marketed Drugs
01
02
04
03
Drug- Orbactiv
Company- The Medicines Company
Drug- Sivextro
Company- Cubist Pharmaceutical
Drug- Nuzyra
Company- Paratek Pharmaceutical
Drug- Baxdela
Company- Melinta
DelveInsight © 2019 | All rights reserved

6. DelveInsight © 2019 | All rights reserved
For complete information on
Acute Bacterial Skin and Skin-Structure Infection (ABSSSI) -Market Insights, Epidemiology &Market Forecast-2028
please click the link below
CLICK HERE
OR
Write Us At
info@delveinsight.com
Complete Information

7. About
DelveInsight is a premier Business Consulting
and Market Research firm focused exclusively on
the life science segment. With a wide array of
smart end-to-end solutions, the firm helps the
global Pharmaceutical and Bio-Tech companies
formulate prudent business decisions for
improving their performances to stay ahead of
the competitors.
Mission
To provide “insights across the value chain” and
helping the organization to take a prudent
business decision through the use and analysis of
actionable market intelligence. The mission also
is to provide the most effective result and
efficient service with utmost client care for
maintaining a long-term relationship with them.
Vision
To be the most trusted market research &
business consulting firm in the world; and to
continue enable the Pharma & Bio-Tech
companies to achieve their goals with the best
strategic insight and competitive solution. The
vision also is inclusive of becoming a one-stop
solution provider for the entire gamut of drug
development process.
1 2 3
DelveInsight © 2019 | All rights reserved
About DelveInsight

8. Opportunity
Assessment5
Report Store6
Competitive
Analysis7
PharmDelve8
Forecasting 1
Pipeline 2
Consulting 3
Market Intelligence 4
DelveInsight © 2019 | All rights reserved
Service Offerings by DelveInsight

9. DelveInsight © 2018 | All rights reserved
Contact Us
info@delveinsight.com
+91-11-4568 9769
www.delveinsight.com
blog/delveInsight/
twitter/delveInsight
LinkedIn/delveInsight